Thus, in this study, we performed the expression profile analyses of the TMPRSS2 gene for COVID‐19 in different normal tissues and PRAD (prostate adenocarcinoma) tumour tissues as a marker for targeted therapy.19, 20, 21. This evidence concerns the gene TMPRSS2 and COVID-19.